For an academic scientist, Lee Rubin at the Harvard Stem Cell Institute (HSCI) has a great deal of biotech industry experience, and this has inspired some ingenious experiments with induced pluripotent stem cells (iPSCs) for disease modeling and drug discovery.

FORBES: Using Stem Cells To Identify Better (And Cheaper) Drugs